Navigation Links
PolyTouch Medical Ltd. Announces the Submission of a Premarket Application for PatchAssist - an Innovative Mesh Deployment and Placement Device for Laparoscopic Hernia Repair
Date:5/3/2010

MISGAV, Israel, May 3, 2010 /PRNewswire/ -- PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.

PatchAssist is a standalone surgical mesh placement device that is compatible with all common hernia meshes and supports a wide span of mesh sizes including the largest mesh sizes in the market. PatchAssist enables surgeons to choose their preferred mesh during LVHR procedures.

"We are extremely excited to have reached this value-creating milestone with the filing of a Premarket 510(k) Application for PatchAssist," said Ofek Levin, Founder and CEO of PolyTouch Medical. "LVHR is a relatively complicated laparoscopic procedure mainly due to the hurdle of mesh deployment and placement stage. With over 400,000 annual ventral hernia repair procedures in the US, and with laparoscopic surgeries growing over 21% annually, we believe that PatchAssist will become the standard of care in LVHR, will reduce operation time and costs, and will enable an easier and shorter learning curve for surgeons who wish to convert from the open technique to the laparoscopic repair. We are receiving strong indications from surgeons, at all levels of experience, that the product answers a clear clinical need and that they look forward to using this device once it is cleared." Mr. Levin added, "We are currently reviewing several commercial strategies for bringing PatchAssist to market following clearance of the 510(k) pre-market application. Clinical and commercial interest in patch Assist is extremely high. Recent clinical surveys conducted during the American Hernia Society Congress on Orlando last month, suggests that nearly half of surgeons performing LVHR will switch to an alternate surgical mesh if offered with Patch Assist."

David Earle, MD, FACS, Assistant Professor of Surgery, Tufts University School of Medicine, PolyTouch's Medical Advisor commented: "When I first saw the device, I was intrigued. It had the potential to really improve the way both specialists and general surgeons perform laparoscopic hernia repair. When I first used the device, I was convinced."

As previously reported, PolyTouch announced on April 26th, the appointment of Karl A. LeBlanc, MD, MBA, FACS, as Medical Advisor. Additionally, PolyTouch announced April 12th, the appointment of Morris E. Franklin Jr., MD, FACS, as Medical Advisor. On January 25th, PolyTouch announced the appointment of William Edelman as Chairman of the Board.

About PolyTouch Medical Ltd.

PolyTouch Medical was founded in March 2009 and is located in the Misgav Venture Accelerator, Israel. Realizing the need for an improved method for mesh deployment and placement, PolyTouch has developed PatchAssist (patents pending), a novel and proprietary mesh deployment and placement device initially targeting laparoscopic ventral hernia repair (LVHR). PatchAssist is a standalone surgical mesh placement device that is compatible with all common hernia meshes enabling the surgeons to choose their preferred mesh during LVHR procedures and it supports a wide span of mesh sizes including the largest mesh size category. PatchAssist enables accurate abdominal cavity mesh placement, potentially reducing procedure time by 30%-50%. PolyTouch plans to introduce the PatchAssist device into the U.S. market in the beginning of 2011.

    Contact:
    Ofek Levin, Founder & CEO
    PolyTouch Medical Ltd,
    Email: ofek@polytouch-med.com
    Phone: +972-72-260-7066


'/>"/>
SOURCE PolyTouch Medical Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioMS Medical updates University of Alberta equity position
2. InterTech Service to Counter Widely Reported Problems in Automotive, Medical Device and Other Industries Requiring Rigorous Quality Standards
3. Veran Medical Technologies First SPiN Drive Installation at Duke Medical Center
4. Maine Medical Center Chooses Business Intelligence Solution from Rapid Insight Inc.
5. DNA Genotek's Oragene•DNA Product Wins Prestigious Medical Design Excellence Award
6. Ministry of Cannabis: A Growing Collection of Medical Cannabis Seeds
7. BioMS Medical Announces 2009 Year End Results
8. Elbit Imaging Announces Filing of Draft Prospectus for its Subsidiary Elbit Medical Ltd. for Float on Tel Aviv Stock Exchange
9. ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer
10. Medical Device Designers Avoid the Pitfalls of Outsourcing Medical Tubing
11. SPO Medical Secures Agreement in Sleep Apnea Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... Personal eye wash is a basic first aid ... at a time. So which eye do you rinse first if a dangerous substance enters ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its dirt ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., a ... Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas ... practices and how Proscia improves lab economics and realizes an increase in diagnostic ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... compared the implantation and pregnancy rates in frozen and fresh in vitro ... of progesterone and maternal age to IVF success. , After comparing the results ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
Breaking Biology News(10 mins):